Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Teleflex Inc (TFX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 9,537,109
  • Shares Outstanding, K 44,980
  • Annual Sales, $ 1,868 M
  • Annual Income, $ 237,380 K
  • 36-Month Beta 1.06
  • Price/Sales 5.19
  • Price/Cash Flow 20.51
  • Price/Book 4.37

Price Performance

See More
Period Period Low Period High Performance
1-Month
204.18 +3.06%
on 07/06/17
216.37 -2.75%
on 07/25/17
+4.69 (+2.28%)
since 06/27/17
3-Month
191.40 +9.94%
on 05/15/17
216.37 -2.75%
on 07/25/17
+3.96 (+1.92%)
since 04/27/17
52-Week
136.53 +54.12%
on 10/28/16
216.37 -2.75%
on 07/25/17
+35.68 (+20.42%)
since 07/27/16

Most Recent Stories

More News
MedTech Stocks to Top Q2 Estimates

Most of the MedTech majors are lined up to report their earnings results over the next week.

Q : 91.59 (-0.12%)
DXTR : 0.25 (unch)
TFX : 210.42 (-0.76%)
IDXX : 164.40 (-1.46%)
What's in the Cards for DaVita (DVA) this Earnings Season?

Despite a stable Kidney Care business, escalating expenses is likely to mar DaVita's (DVA) performance in the second quarter.

DXTR : 0.25 (unch)
TMO : 175.27 (+0.12%)
TFX : 210.42 (-0.76%)
DVA : 64.88 (-0.02%)
Arrow(R) Seldinger Arterial Catheterization Device Receives FDA Market Clearance

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced today that its Arrow(R) Seldinger Arterial Catheterization...

TFX : 210.42 (-0.76%)
Boston Scientific (BSX) Q2 Earnings: What Awaits the Stock?

Lower TAVR sales due to recall of Lotus valves within the European and other key markets is likely to mar Boston Scientific's (BSX) top-line performance in Q2.

DXTR : 0.25 (unch)
BSX : 27.05 (-1.35%)
TMO : 175.27 (+0.12%)
TFX : 210.42 (-0.76%)
LabCorp (LH) Q2 Earnings: Is Disappointment in the Cards?

With the Covance Drug Diagnostic arm's revenue and margins projected to decline further, LabCorp???s business in Q2 might face disruption.

DXTR : 0.25 (unch)
TMO : 175.27 (+0.12%)
TFX : 210.42 (-0.76%)
LH : 160.10 (-0.66%)
Teleflex Announces Second Quarter 2017 Earnings Conference Call Information

Teleflex Incorporated (NYSE: TFX) announced today that financial results for the second quarter 2017 will be released before market open on Thursday, August 3, 2017. An investor conference...

TFX : 210.42 (-0.76%)
What's in Store for athenahealth (ATHN) in Q2 Earnings?

athenahealth Inc. (ATHN) is set to report second-quarter 2017 results on Jul 20.

DXTR : 0.25 (unch)
ATHN : 140.97 (-3.28%)
TMO : 175.27 (+0.12%)
TFX : 210.42 (-0.76%)
Will Intuitive Surgical (ISRG) Surprise in Q2 Earnings?

Intuitive Surgical Inc. (ISRG) is scheduled to report second-quarter 2017 results after the closing bell on Jul 20.

DXTR : 0.25 (unch)
TMO : 175.27 (+0.12%)
TFX : 210.42 (-0.76%)
ISRG : 931.85 (-1.28%)
Will Thermo Fisher's (TMO) Q2 Earnings Surpass Expectations?

Strong focus on product launch and emerging market expansion should drive Thermo Fisher (TMO) toward an earnings beat in Q2.

DXTR : 0.25 (unch)
SYK : 144.05 (-1.17%)
TMO : 175.27 (+0.12%)
TFX : 210.42 (-0.76%)
Can Abbott Laboratories (ABT) Pull a Surprise in Q2 Earnings?

Abbott Laboratories (ABT) is scheduled to report second-quarter 2017 results before the opening bell on Jul 20.

DXTR : 0.25 (unch)
ABT : 50.11 (-0.58%)
TMO : 175.27 (+0.12%)
TFX : 210.42 (-0.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Teleflex Inc. designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company offers its products to hospitals and healthcare providers through its direct sales force and distributors....

See More

Support & Resistance

2nd Resistance Point 214.78
1st Resistance Point 212.60
Last Price 210.42
1st Support Level 208.40
2nd Support Level 206.38

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.